Epoch Biodesign

About:

Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.

Website: https://epochbiodesign.com/

Twitter/X: epochbio

Top Investors: BoxGroup, Plug and Play, Lowercarbon Capital, Ascension, Possible Ventures

Description:

Epoch Biodesign develops natural solutions to scale and industrialize biology to solve climate challenges. Epoch Biodesign develops enzymes to enable previously unthinkable applications by combining unique insights from nature with deep expertise in computational and biological sciences. The company's solution is biorecycling, which is a tuneable enzymatic process that converts plastic waste into everyday chemicals.

Total Funding Amount:

$16M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2019-01-01

Contact Email:

hello(AT)epochbiodesign.com

Founders:

Douglas Kell, Jacob Nathan

Number of Employees:

11-50

Last Funding Date:

2024-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai